Literature DB >> 9480916

High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.

M K Sievert1, D S Thiriot, R H Edwards, A E Ruoho.   

Abstract

The full-length cDNA for the rat synaptic-vesicle monoamine transporter (VMAT2) containing a C-terminal polyhistidine epitope has been engineered into baculovirus DNA for expression in Spodoptera frugiperda (Sf9) insect cells. Using this recombinant baculovirus and cultured Sf9 cells, rVMAT2 has been expressed at levels of 7.8x10(6) transporters per cell, as assessed by [3H]dihydrotetrabenazine binding. A 1l culture of infected cells produced approx. 15 nmol (900 microg) of transporter. rVMAT2 expressed in the Sf9 cells bound [3H]dihydrotetrabenazine with a KD of 31.2 nM and a Bmax of 19.9 pmol/mg. Two polypeptides of 55 and 63 kDa were identified using the photolabel, 7-azido-8-[125I]iodoketanserin ([125I]AZIK). Photoaffinity labelling of rVMAT2 by 1 nM [125I]AZIK was protectable by 10 microM tetrabenazine and 10 microM 7-aminoketanserin. Digitonin-solubilized VMAT2 was purified to greater than 95% homogeneity using immobilized Ni2+-affinity chromatography, followed by lectin (Concanavalin A) chromatography. The purified transporter migrates as a single broad band with a molecular mass of approx. 63kDa, as analyzed by SDS/PAGE. The purified transporter retained the ability to bind ligands ([125I]AZIK and [3H]dihydrotetrabenazine). The purified VMAT2 bound [3H]dihydrotetrabenazine with a KD of 86.2 nM. As is the case with the monoamine transporter from bovine chromaffin granule membranes, purified VMAT2 is covalently modified by dicyclohexylcarbodi-imide (DCCD) and is specifically labelled by [14C]DCCD. This labelling is inhibited by tetrabenazine and ketanserin. These data indicate that VMAT2 can be overexpressed using the baculovirus expression system and purified.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9480916      PMCID: PMC1219231          DOI: 10.1042/bj3300959

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles.

Authors:  J P Henry; D Scherman
Journal:  Biochem Pharmacol       Date:  1989-08-01       Impact factor: 5.858

2.  Covalent modification of the amine transporter with N,N'-dicyclohexylcarbodiimide.

Authors:  R Suchi; Y Stern-Bach; T Gabay; S Schuldiner
Journal:  Biochemistry       Date:  1991-07-02       Impact factor: 3.162

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport.

Authors:  R G Johnson
Journal:  Physiol Rev       Date:  1988-01       Impact factor: 37.312

5.  [3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain.

Authors:  D Scherman; R Raisman; A Ploska; Y Agid
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

6.  [Binding of a tetrabenazine derivative to the monoamine transporter of the chromaffin granule membrane].

Authors:  D Scherman; P Jaudon; J P Henry
Journal:  C R Seances Acad Sci III       Date:  1981-10-05

7.  Protonmotive force and catecholamine transport in isolated chromaffin granules.

Authors:  R G Johnson; A Scarpa
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

8.  Dicyclohexylcarbodiimide inhibits the monoamine carrier of bovine chromaffin granule membrane.

Authors:  B Gasnier; D Scherman; J P Henry
Journal:  Biochemistry       Date:  1985-02-26       Impact factor: 3.162

9.  1-Methyl-4-phenylpyridinium is a substrate of the vesicular monoamine uptake system of chromaffin granules.

Authors:  D Scherman; F Darchen; C Desnos; J P Henry
Journal:  Eur J Pharmacol       Date:  1988-02-09       Impact factor: 4.432

10.  Stoichiometry of H+-linked dopamine transport in chromaffin granule ghosts.

Authors:  J Knoth; M Zallakian; D Njus
Journal:  Biochemistry       Date:  1981-11-10       Impact factor: 3.162

View more
  4 in total

1.  Expression of neurotransmitter transporters for structural and biochemical studies.

Authors:  Yael Elbaz; Tsafi Danieli; Baruch I Kanner; Shimon Schuldiner
Journal:  Protein Expr Purif       Date:  2010-06-08       Impact factor: 1.650

2.  Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

Authors:  Nicholas V Cozzi; Anupama Gopalakrishnan; Lyndsey L Anderson; Joel T Feih; Alexander T Shulgin; Paul F Daley; Arnold E Ruoho
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

3.  Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels.

Authors:  Michael K Sievert; Abdol R Hajipour; Arnold E Ruoho
Journal:  Anal Biochem       Date:  2007-05-03       Impact factor: 3.365

4.  Expression and purification of recombinant vesicular glutamate transporter VGLUT1 using PC12 cells and High Five insect cells.

Authors:  Søren S L Andersen
Journal:  Biol Proced Online       Date:  2004-06-07       Impact factor: 3.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.